Market Closed

APVO
Aptevo Therapeutics
$ 0.5941
-10.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Aptevo Therapeutics News

Latest Aptevo Therapeutics Stock News & APVO Headlines

Aptevo Therapeutics Inc. (NASDAQ:APVO) Stock Short Interest Rises 59.0%
a month ago | defenseworld.net
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
2 months ago | accessnewswire.com
Aptevo Therapeutics (NASDAQ:APVO) Share Price Passes Below 50 Day Moving Average – Should You Sell?
2 months ago | defenseworld.net
Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial
2 months ago | benzinga.com
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
3 months ago | accessnewswire.com
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
3 months ago | accessnewswire.com
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
3 months ago | accessnewswire.com
Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
4 months ago | accessnewswire.com
Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors
5 months ago | accessnewswire.com
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D.
6 months ago | accessnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

APVO
Aptevo Therapeutics
$ 0.5941
-10.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago